Hunter Associates Investment Management LLC Unicycive Therapeutics, Inc. Transaction History
Hunter Associates Investment Management LLC
- $657 Million
- Q4 2024
A detailed history of Hunter Associates Investment Management LLC transactions in Unicycive Therapeutics, Inc. stock. As of the latest transaction made, Hunter Associates Investment Management LLC holds 15,000 shares of UNCY stock, worth $8,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$8,400% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding UNCY
# of Institutions
32Shares Held
61.7MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT11MShares$6.15 Million5.72% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT10.4MShares$5.82 Million0.41% of portfolio
-
Octagon Capital Advisors LP New York, NY10MShares$5.6 Million1.76% of portfolio
-
Vivo Capital, LLC Palo Alto, CA9.97MShares$5.58 Million1.54% of portfolio
-
Logos Global Management LP San Francisco, CA5.08MShares$2.84 Million0.53% of portfolio
About Unicycive Therapeutics, Inc.
- Ticker UNCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,052,500
- Market Cap $8.43M
- Description
- Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...